Jianting S. Long
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.
Journal: JAMA oncology
Published: January 29, 2026
Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 27, 2025
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 23, 2025
Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma.
Journal: Cancer & metabolism
Published: March 11, 2025
Retraction Notice to: MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells.
Journal: Molecular therapy. Oncology
Published: January 06, 2025
m6 A-Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 17, 2022
Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report.
Journal: Frontiers in immunology
Published: May 11, 2022
METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Journal: Cancer research
Published: March 22, 2022
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population.
Journal: BMC cancer
Published: January 14, 2022
Last Updated: 09/26/2026